1
|
Aleksova A, Fluca AL, Janjusevic M, Padoan L, Pierri A, Chiaradia V, Munaretto L, Merro E, Barbati G, Hiche C, Gabrielli M, Lovadina S, Beltrame D, D'Errico S, Saw J, Fabris E, Di Lenarda A, Sinagra G. Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study. Int J Cardiol 2025; 420:132745. [PMID: 39592072 DOI: 10.1016/j.ijcard.2024.132745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/19/2024] [Revised: 11/07/2024] [Accepted: 11/14/2024] [Indexed: 11/28/2024]
Abstract
BACKGROUND Myocardial infarction with non-obstructive coronary arteries (MINOCA) and type 2 myocardial infarction (MI), both presenting as non-ST-elevation MI (NSTEMI), are often grouped together due to overlapping symptoms. The aim of our study is to compare their characteristics and prognosis to distinguish between them. METHODS Among 7815 patients with NSTEMI who underwent coronary angiography between 2005 and 2022 we identified 538 patients with diagnosis of MINOCA (n = 301; 3,9 %) and type 2 MI (n = 237; 3 %). The outcome was a composite of all-cause mortality, non-fatal MI, hospitalisation for heart failure (HF) and transitory ischemic attack or non-fatal stroke. RESULTS The mean age of the entire cohort was 68 (11.5) years, with women being the most frequently represented group (65 %). Comparing the sub-cohorts, MINOCA patients were younger (66.3 (11.7) Vs. 70.6 (11) years, p < 0.01), and less likely to have typical cardiovascular risk than type 2 MI patients. At multivariable analysis different clinical (age, heart rate, typical chest pain, palpitations, postmenopausal status), and instrumental (cardiac rhythm, ST-segment changes, diastolic dysfunction, hypo/akinesia with non-coronary distribution) variables were independent predictors of MINOCA with AUC of 0.83 [95 % CI, 0.78-0.88], p < 0.01 at ROC analysis. At a median follow-up of 61 (IQR 34-100) months, MINOCA patients had significantly lower rate of the composite endpoint compared to type 2 MI (20 % Vs. 32 %, p < 0.01). CONCLUSIONS MINOCA cohort was associated with different characteristics compared to type 2 MI and had a better prognosis despite the number of events was not negligible.
Collapse
Affiliation(s)
- Aneta Aleksova
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy.
| | - Alessandra Lucia Fluca
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| | - Milijana Janjusevic
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| | - Laura Padoan
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiology Department, Gorizia-Monfalcone, Gorizia, Italy
| | - Alessandro Pierri
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Cardiology Department and Intensive Coronary Care UTIC, San Paolo Hospital, Bari, Italy
| | | | - Laura Munaretto
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| | - Enzo Merro
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| | | | - Cristina Hiche
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy
| | - Marco Gabrielli
- Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| | - Stefano Lovadina
- Department of General and Thoracic Surgery, Cattinara University Hospital, Trieste, Italy
| | - Daria Beltrame
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy
| | - Stefano D'Errico
- Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| | - Jacqueline Saw
- Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada
| | - Enrico Fabris
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| | - Andrea Di Lenarda
- Cardiovascular Center, University Hospital and Health Services of Trieste, Trieste, Italy
| | - Gianfranco Sinagra
- Azienda Sanitaria Universitaria Giuliano Isontina, Cardiothoracovascular Department, Trieste, Italy; Laboratory of Molecular Cardiology, Department of Medical Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy
| |
Collapse
|